Characterization of gelatinase from pig polymorphonuclear leucocytes. A metalloproteinase resembling tumour type IV collagenase.
about
Matrix metalloproteinase and tissue inhibitor of metalloproteinase responses to muscle damage after eccentric exerciseCharacterization and activation of procollagenase from human polymorphonuclear leucocytes. N-terminal sequence determination of the proenzyme and various proteolytically activated formsTear film MMP accumulation and corneal diseaseIncreased ADAMTS-13 proteolytic activity in rat hepatic stellate cells upon activation in vitro and in vivoMajor co-localization of the extracellular-matrix degradative enzymes heparanase and gelatinase in tertiary granules of human neutrophils.Immunolocalisation studies on six matrix metalloproteinases and their inhibitors, TIMP-1 and TIMP-2, in synovia from patients with osteo- and rheumatoid arthritis.Genetic polymorphisms of matrix metalloproteinases and their inhibitors in potentially malignant and malignant lesions of the head and neck.Matrix metalloproteinases in the formation of human synovial joint cavitiesMembrane type 4 matrix metalloproteinase (MMP17) has tumor necrosis factor-alpha convertase activity but does not activate pro-MMP2.Expression of 92-kD type IV collagenase/gelatinase (gelatinase B) in osteoarthritic cartilage and its induction in normal human articular cartilage by interleukin 1.Human 72-kilodalton type IV collagenase forms a complex with a tissue inhibitor of metalloproteases designated TIMP-2Matrix metalloproteinase inhibitors: do they have a place in anticancer therapy?Meta-analysis of MMP2, MMP3, and MMP9 promoter polymorphisms and head and neck cancer risk.Recombinant viral protein promotes apoptosis and suppresses invasion of ovarian adenocarcinoma cells by targeting α5β1 integrin to down-regulate Akt and MMP-292-kd gelatinase is actively expressed by eosinophils and stored by neutrophils in squamous cell carcinomaGenes of laminin B1 chain, alpha 1 (IV) chain of type IV collagen, and 72-kd type IV collagenase are mainly expressed by the stromal cells of lung carcinomas.Density-dependent induction of 92-kd type IV collagenase activity in cultures of A431 human epidermoid carcinoma cells.Activity of type IV collagenases in benign and malignant breast diseaseThe expression of matrix metalloproteinase 9 is enhanced by Epstein-Barr virus latent membrane protein 1MMP 9 Gene Promoter Polymorphism in Gastric Cancer.Regulation of MT1-MMP/MMP-2/TIMP-2 axis in human placenta.High expression of 92-kD type IV collagenase (gelatinase B) in the osteoclast lineage during mouse development.Matrix metalloproteinases MMP2 and MMP9 are produced in early stages of kidney morphogenesis but only MMP9 is required for renal organogenesis in vitro.92-kD type IV collagenase mediates invasion of human cytotrophoblasts.Interleukin-1alpha-induced proteolytic activation of metalloproteinase-9 by human skinIn vivo suppression of immune complex-induced alveolitis by secretory leukoproteinase inhibitor and tissue inhibitor of metalloproteinases 2Essential role of matrix metalloproteinases in interleukin-1-induced myofibroblastic activation of hepatic stellate cell in collagen.Transforming growth factor-beta - and tumor necrosis factor-alpha -mediated induction and proteolytic activation of MMP-9 in human skin.Distribution of the matrix metalloproteinases stromelysin, gelatinases A and B, and collagenase in Crohn's disease and normal intestine.Secreted or nonsecreted forms of acidic fibroblast growth factor produced by transfected epithelial cells influence cell morphology, motility, and invasive potential.Matrix metalloproteinases limit functional recovery after spinal cord injury by modulation of early vascular events.Binding of gelatinases A and B to type-I collagen and other matrix components.Acetyl-L-Carnitine Prevents Methamphetamine-Induced Structural Damage on Endothelial Cells via ILK-Related MMP-9 Activity.Walker 256 cancer cells secrete tissue inhibitor of metalloproteinase-free metalloproteinase-9.Protease analysis by neoepitope approach reveals the activation of MMP-9 is achieved proteolytically in a test tissue cartilage model involved in bone formation.Adhesion molecules and their role in cancer metastasis.Extracellular matrix-degrading proteinases in the nervous system.Role of matrix metalloproteinases in human periodontal diseases.Type IV collagenases in invasive tumors.Matrix metalloproteinase 2 (MMP2) and MMP9 are produced by kidney collecting duct principal cells but are differentially regulated by SV40 large-T, arginine vasopressin, and epidermal growth factor.
P2860
Q28066118-A5D42E6C-4F06-4587-9500-94FE6AFF5FC8Q28238221-1D203A6F-4209-4BEA-9BA0-85993C70486DQ28346325-0518DFD5-A135-4B16-AC46-22FB34542E27Q28584350-18C030B7-5789-4A6C-8F99-FA135EE4C52DQ32064429-AF31486E-D91D-4FA1-90E6-C97FF2279CB9Q33566911-1DD24A17-BB7E-4758-AB56-2D7D3637C1C5Q33758871-EA742BD3-6B62-4FD9-90E1-E0A67FB2A2C5Q33881795-59B5EA6D-7FD7-42BC-9F00-A8BFC9F4EA98Q33900860-579242E7-03FD-45F9-BDAE-515508331A09Q34111117-FB5C58BA-8355-429E-9B88-BEF5C2B306F3Q34314710-F4953EC8-B25D-4185-AFBE-E3FB6B742BDBQ34687431-E601B885-E4A4-4A4B-B2EB-A6C2AC49E9EEQ34700849-0A21E550-6CCD-492D-9D38-D50FD32F5083Q35708197-7BCC8502-EE30-4BB0-8C37-16757A664D59Q35832706-46C40F5D-5857-41B4-B5F8-AA969F65E32BQ35832843-0BCC5C94-23A8-462E-8A87-08A4B43CDF82Q35833895-60839EB3-3B14-4AF8-AAD0-7BBA2FB4F07DQ35976755-2F91EA9D-F68B-48FF-A8E7-F15F6A6D13A2Q36006767-CD0DCDAE-2CF9-485E-82D7-01DAA3A53A58Q36079981-958EEE79-5132-47FF-83C2-DC6C7342508DQ36140125-D9B1885A-BE77-42AE-812D-BE9389E7DF0FQ36233850-E2F9BA2F-3797-4ED1-9A2B-0D37DC1DF94AQ36254654-DF2052E0-B0C4-441A-B031-945DA49B48FFQ36529534-D3516C11-219F-48BE-8B2E-D22E8F4E82CFQ36631274-B72CF13D-2D99-416F-AFD0-7170BBD1477AQ36711493-8B88C96D-C9C2-4A0D-A33E-7BF8281B1A88Q36727057-629A461B-E817-4B34-8903-E79236E2EE9EQ37118844-4A95C0DB-2053-4FC9-B01B-9FA2EAA7849CQ37246271-C3B09E83-BD7D-4306-AA09-D6A0B1D830F4Q37467404-DB29E5D0-74EF-4740-ABB0-B4C36FEDA120Q37471962-59BC79E4-5727-4916-BE1F-30BF9BA210E0Q38293871-7A669E18-65CC-4016-B3CF-AC997793C226Q38933060-13E57CDA-4009-45AE-9298-2F651AC7F6E3Q39866899-68061974-43C7-475F-9A9A-FB29858E7860Q40278232-24D42B69-8E9B-42BE-8B91-02F8D5D9589DQ40615153-1EBF4F2F-8960-476A-B60F-641435F8AC0CQ40689757-A0B582C5-BD0B-4BF4-9FC8-E27EF43A7807Q40818071-34ECA1DA-A0EC-47F6-B531-156357963DF7Q40877531-1F06C6D0-7887-4A78-ACA6-4C0B4AE33C89Q40982613-A0EC5E14-4225-4145-AC52-B890ED9543FD
P2860
Characterization of gelatinase from pig polymorphonuclear leucocytes. A metalloproteinase resembling tumour type IV collagenase.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
1989年论文
@zh
1989年论文
@zh-cn
name
Characterization of gelatinase ...... ng tumour type IV collagenase.
@en
Characterization of gelatinase ...... ng tumour type IV collagenase.
@nl
type
label
Characterization of gelatinase ...... ng tumour type IV collagenase.
@en
Characterization of gelatinase ...... ng tumour type IV collagenase.
@nl
prefLabel
Characterization of gelatinase ...... ng tumour type IV collagenase.
@en
Characterization of gelatinase ...... ng tumour type IV collagenase.
@nl
P2093
P2860
P356
P1433
P1476
Characterization of gelatinase ...... ng tumour type IV collagenase.
@en
P2093
P2860
P304
P356
10.1042/BJ2580463
P407
P577
1989-03-01T00:00:00Z